These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 14617731)

  • 1. Adult paraneoplastic opsoclonus-myoclonus syndrome associated with antimitochondrial autoantibodies.
    Blaes F; Jauss M; Kraus J; Oschmann P; Krasenbrink I; Kaps M; Teegen B
    J Neurol Neurosurg Psychiatry; 2003 Nov; 74(11):1595-6. PubMed ID: 14617731
    [No Abstract]   [Full Text] [Related]  

  • 2. Paraneoplastic opsoclonus-myoclonus ataxia associated with non-small-cell lung carcinoma.
    Musunuru K; Kesari S
    J Neurooncol; 2008 Nov; 90(2):213-6. PubMed ID: 18618225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Paraneoplastic opsoclonus-myoclonus syndrome associated with small-cell lung cancer].
    Margery J; Ferroir JP; Epaud C; Martin C; Milleron B
    Rev Pneumol Clin; 2003 Nov; 59(5 Pt 1):321-4. PubMed ID: 14707930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paraneoplastic overlap syndrome in non-small squamous cell lung carcinoma.
    Hoque R; DelRosso L
    BMJ Case Rep; 2014 Mar; 2014():. PubMed ID: 24667991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ANNA-2: an antibody associated with paraneoplastic opsoclonus in a patient with large-cell carcinoma of the lung with neuroendocrine features--correlation of clinical improvement with tumor response.
    Erlich R; Morrison C; Kim B; Gilbert MR; Alrajab S
    Cancer Invest; 2004; 22(2):257-61. PubMed ID: 15199608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paraneoplastic neurological disorders.
    Blaes F; Tschernatsch M
    Expert Rev Neurother; 2010 Oct; 10(10):1559-68. PubMed ID: 20925471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opsoclonus-myoclonus: paraneoplastic syndrome associated with renal adenocarcinoma].
    Gimeno Campos MJ; Sanchis Mínguez C; Díez de Diego P; Sánchez Villasante J
    Rev Esp Anestesiol Reanim; 2006 Jan; 53(1):54-5. PubMed ID: 16475641
    [No Abstract]   [Full Text] [Related]  

  • 8. Paraneoplastic Encephalomyelitis With Glutamic Acid Decarboxylase Antibodies Presenting as Longitudinal Pyramidal Tract Hyperintensity.
    Miralles O; Caballol N; Velasco R
    JAMA Neurol; 2020 Jul; 77(7):899-900. PubMed ID: 32391867
    [No Abstract]   [Full Text] [Related]  

  • 9. Subacute Supranuclear Palsy in anti-Hu Paraneoplastic Encephalitis.
    Ohyagi M; Ishibashi S; Ohkubo T; Kobayashi Z; Mizusawa H; Yokota T; Emoto H; Kiyosawa M
    Can J Neurol Sci; 2017 Jul; 44(4):444-446. PubMed ID: 28767032
    [No Abstract]   [Full Text] [Related]  

  • 10. SOX-1 autoantibodies in patients with paraneoplastic neurological syndromes.
    Tschernatsch M; Gross O; Kneifel N; Kaps M; Blaes F
    Autoimmun Rev; 2009 Jun; 8(7):549-51. PubMed ID: 19393214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Paraneoplastic opsoclonus myoclonus syndrome].
    Fujii A; Yoneda M; Kuriyama M
    Ryoikibetsu Shokogun Shirizu; 2000; (29 Pt 4):344-6. PubMed ID: 11031965
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comments on the review by R. Kaiser. Paraneoplastic neurological syndromes, diagnostic and pathogenetic significance of autoantibodies].
    Pfadenhauer K
    Nervenarzt; 2000 Feb; 71(2):143-4. PubMed ID: 10703018
    [No Abstract]   [Full Text] [Related]  

  • 13. Paraneoplastic Opsoclonus-Myoclonus Syndrome: initial presentation of non-Hodgkins lymphoma.
    Kumar A; Lajara-Nanson WA; Neilson RW
    J Neurooncol; 2005 May; 73(1):43-5. PubMed ID: 15933816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer.
    Nichols JL; Lee BJ; Chung KA
    Tremor Other Hyperkinet Mov (N Y); 2020 Jun; 10():7. PubMed ID: 32775021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment-refractory paraneoplastic opsoclonus-myoclonus syndrome in a patient with small-cell carcinoma of the lung.
    Alkan A; Cenikli U; Uylaş S; Yılmaz M; Çakır T; Çetinkaya H; Kıran A; Tanrıverdi Ö
    J Oncol Pharm Pract; 2020 Jan; 26(1):209-211. PubMed ID: 30791855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-CV2 autoantibodies and paraneoplastic neurological syndromes.
    Rogemond V; Honnorat J
    Clin Rev Allergy Immunol; 2000 Aug; 19(1):51-9. PubMed ID: 11064826
    [No Abstract]   [Full Text] [Related]  

  • 17. Post-streptococcal opsoclonus-myoclonus syndrome associated with anti-neuroleukin antibodies.
    Candler PM; Dale RC; Griffin S; Church AJ; Wait R; Chapman MD; Keir G; Giovannoni G; Rees JH
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):507-12. PubMed ID: 16543530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paraneoplastic Neurological Syndromes: A Condition of Increasing Recognition.
    Seluk L; Kivity S
    Isr Med Assoc J; 2018 Oct; 20(10):649-650. PubMed ID: 30324785
    [No Abstract]   [Full Text] [Related]  

  • 19. Surface-binding autoantibodies to cerebellar neurons in opsoclonus syndrome.
    Blaes F; Fühlhuber V; Korfei M; Tschernatsch M; Behnisch W; Rostasy K; Hero B; Kaps M; Preissner KT
    Ann Neurol; 2005 Aug; 58(2):313-7. PubMed ID: 15988749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Small cell lung cancer associated with anti-Hu antibody-positive paraneoplastic neurologic syndrome].
    Kuronuma K; Nishiyama K; Murakami S; Tanaka N; Takahashi M; Kojima H; Fujishima T; Tanaka H; Takahashi H; Koba H; Tanaka K; Abe S
    Nihon Kokyuki Gakkai Zasshi; 2000 Feb; 38(2):148-52. PubMed ID: 10774176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.